GlassScriptPhysician profile
Andrew Dugan
NPI 1659838092
$1,753.56
in general payments reported to CMS, 2019-2025
17 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $398 · 2023: $487 · 2024: $506 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $616.57 | 2021-2025 | |
| Abiomed | $181.53 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.84 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $121.18 | 2024-2025 | Assure Wcd |
| Medtronic, INC. | $102.71 | 2023-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Astrazeneca Pharmaceuticals LP | $99.22 | 2021-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $84.82 | 2022-2024 | Xarelto |
| Philips North America LLC | $67.39 | 2023-2024 | (792) Multi Modality Ivus Other Systems, (Ck7) Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.46 | 2022-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $55.59 | 2023 | Verquvo |
| Pfizer INC. | $41.84 | 2023-2024 | |
| Convatec INC. | $32.24 | 2024 | |
| Amgen INC. | $30.69 | 2022-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $26.86 | 2022-2023 | Camzyos |
| Boston Scientific Corporation | $25.66 | 2024 | Angiojet Ultra 5000a |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.83 | 2022 | |
| Edwards Lifesciences Corporation | $16.13 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dugan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.